Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

News > All

Total search results: 9816 | Ordered by Date (descending)
1 2 3 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Evotec AG. (12/4/18). "Press Release: Evotec and Leo Pharma Form Drug Discovery Alliance Targeting Dermatological Conditions". Hamburg & Ballerup. 2018-12-04
Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour 2018-12-04
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. 2018-12-04
Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Enters Exclusive Global Collaboration and License Agreement with Cilag GmbH International, an Affiliate of Janssen, for Cusatuzumab (ARGX-110)". Breda & Ghent. 2018-12-03
Genedata AG. (12/3/18). "Press Release: Genedata Opens New Subsidiary in Singapore to Support Growing Business in Asia and Australia". Singapore. 2018-12-03
Selexis S.A.. (12/3/18). "Press Release: KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board". Durham, NC & Geneva. 2018-12-03
SpinDiag GmbH. (12/3/18). "Press Release: SpinDiag Closes Second Financing Round of EUR 3.0 million (USD 3.4 million) to Complete Product Development of Its Point-of-Care Screening System for Antibiotic-resistant Bacteria". Freiburg. 2018-12-03
Qiagen N.V.. (11/30/18). "Press Release: Qiagen and NeoGenomics Collaborate to Offer Cancer Patients Day-One Access to Innovative Companion Diagnostics for Newly Approved Drugs". Hilden, Germantown, MD & Fort Myers, FL. 2018-11-30
Forbion Capital Partners. (11/29/18). "Press Release: Forbion Appoints Dr. Carlo Incerti as Operating Partner". Naarden & Munich. 2018-11-29
Marinomed Biotech AG. (11/29/18). "Press Release: Marinomed Suspends Offer Period of the Current IPO [Adhoc-News]". 2018-11-29
Marinomed Biotech AG. (11/28/18). "Press Release: Viennese Biotech Company Marinomed Demonstrates the Benefits of Its Patented Marinosolv Technology". 2018-11-28
Qiagen N.V.. (11/28/18). "Press Release: Qiagen Extends Comprehensive Offering for Cervical Cancer Screening with European Launch of QIAscreen HPV PCR Test". Hilden. 2018-11-28
German Accelerator Life Sciences. (11/27/18). "Press Release: German Accelerator Life Sciences (GALS) Alumni Company SpinDiag Closes € 3M Funding Round". Freiburg & Cambridge, MA. 2018-11-27
Jecure Therapeutics Inc.. (11/27/18). "Press Release: Genentech Acquires Jecure Therapeutics". San Diego, CA. 2018-11-27
Arsanis, Inc.. (11/27/18). "Press Release: Arsanis and X4 Pharmaceuticals Agree to Merger". Cambridge, MA, Waltham, MA & Vienna. 2018-11-27
Adrenomed AG. (11/26/18). "Press Release: Adrenomed Closes EUR 24 M Financing Led by Wellington and HBM". Hennigsdorf, Munich & Zug. 2018-11-26
BRAIN AG. (11/26/18). "Press Release: Suntory Beverage & Food Europe and BRAIN AG Start Joint Development Program". Zwingenberg & Uxbridge. 2018-11-26
Bayer Corporation. (11/26/18). "Press Release: FDA Approves Vitrakvi (larotrectinib), the First Ever TRK Inhibitor, for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion". Whippany, NJ & Stamford, CT. 2018-11-26
MorphoSys AG. (11/26/18). "Press Release: MorphoSys Announces Approval of Tremfya (Guselkumab) in Japan for the Treatment of Patients with Palmoplantar Pustulosis". Planegg. 2018-11-26
Spark Therapeutics, Inc.. (11/23/18). "Press Release: European Commission Approves Spark Therapeutics’ Luxturna (voretigene neparvovec), a One-time Gene Therapy for Inherited Retinal Disease Caused by Confirmed Biallelic RPE65 Mutations". Philadeliphia, 2018-11-23
Merck KGaA. (11/23/18). "Press Release: Merck Appoints Jasper Bos as Managing Director of M Ventures". Darmstadt. 2018-11-23
Curetis N.V.. (11/23/18). "Press Release: Curetis Announces Financial Results for the First Nine Months of 2018". Amsterdam, Holzgerlingen & San Diego, CA. 2018-11-23
F2G Ltd.. (11/22/18). "Press Release: EU Supports F2G Biotech in Austria with EUR 24 Million for Antifungal Research and Innovation". Luxembourg. 2018-11-22
Evotec AG. (11/21/18). "Press Release: Evotec and Immuneering to Collaborate on Artifical Intelligence (“AI”) Driven Ligand Identification for Rare Hereditary Metabolic Diseases". Hamburg & Cambridge, MA. 2018-11-21
InflaRx N.V.. (11/21/18). "Press Release: InflaRx N.V. Reports Third Quarter 2018 Financial & Operating Results". Jena. 2018-11-21
Santhera Pharmaceuticals Holding AG. (11/21/18). "Press Release: Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolone". Pratteln & Allschwil. 2018-11-21
BRAIN AG. (11/21/18). "Press Release: Manfred Bender Set to Join BRAIN AG’s Management Board as Chief Financial Officer (CFO)". Zwingenberg. 2018-11-21
Santhera Pharmaceuticals Holding AG. (11/21/18). "Press Release: Santhera Calls Extraordinary General Meeting and Proposes Ordinary Share Capital Increase to Raise Approximately CHF 50 Million". Pratteln & Allschwil. 2018-11-21
3B Pharmaceuticals GmbH. (11/20/18). "Press Release: Ipsen and 3BP Announce First Patient Dosed in Phase I/II Study for First-in-class Radionuclide (IPN01087)". Paris. 2018-11-20
Merck KGaA. (11/19/18). "Press Release: Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer [Not intended for US, Canada and UK-based media]". Darmstadt. 2018-11-19
Merck KGaA. (11/19/18). "Press Release: Syntropy to Unlock the Value of Scientific Data in Fight to End Cancer. Joint Venture between Merck and Palantir Technologies Being Created to Advance Cancer Research". Palo Alto, CA. 2018-11-19
Immunocore Ltd.. (11/19/18). "Press Release: Immunocore to Co-develop IMC-C103C, a T Cell Redirecting Bi-specific Biologic, with Genentech". Oxford & Conshohocken, PA. 2018-11-19
Noxxon Pharma N.V.. (11/16/18). "Press Release: Noxxon Announces € 6.2 Million Equity Capital Raise including US$ 5 Million from US Family Office – Acuitas Capital, LLC. Noxxon Ends the Use of Variable Rate Equity Financing with Yorkville". Berlin. 2018-11-16
Mologen AG. (11/16/18). "Press Release: Mologen AG to Retain Rights to Lefitolimod – Termination of Negotiations with Oncologie Inc. and Assessment of All Strategic Options in the Light of a Likely Read-out of the Pivotal Phase III IMPALA Trial in 2019". 2018-11-16
Marinomed Biotech AG. (11/16/18). "Press Release: Marinomed Determines IPO Timeline and Terms [Adhoc-News]". 2018-11-16
Apceth Biopharma GmbH. (11/16/18). "Press Release: Apceth Biopharma GmbH Manufactures DCprime’s Cell-based Cancer Vaccine for Phase II Clinical Study". Munich. 2018-11-16
Lonza Group Ltd.. (11/15/18). "Press Release: Lonza and Sartorius Stedim Biotech Modify Relationship for Supply of Cell Culture Media". Basel & Aubagne. 2018-11-15
MorphoSys AG. (11/15/18). "Press Release: MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210". Planegg. 2018-11-15
Boehringer Ingelheim. (11/15/18). "Press Release: Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies". Cambridge, MA & Ingelheim. 2018-11-15
NBE Therapeutics AG. (11/15/18). "Press Release: Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE Therapeutics". Basel. 2018-11-15
Bruker Corporation. (11/14/18). "Press Release: Bruker Announces Agreement for the Acquisition of Alicona Imaging GmbH". Billerica. 2018-11-14
Roivant Sciences GmbH. (11/13/18). "Press Release: Roivant Sciences Announces $200 Million Investment Round". Basel & London. 2018-11-13
Evotec AG. (11/13/18). "Press Release: Evotec AG Reports First Nine-months 2018 Results and Corporate Updates". Hamburg. 2018-11-13
Amal Therapeutics S.A.. (11/12/18). "Press Release: Amal Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round". Geneva. 2018-11-12
Aimmune Therapeutics, Inc.. (11/12/18). "Press Release: Aimmune Therapeutics Announces Additional Equity Investment by Nestlé Health Science". Brisbane, CA. 2018-11-12
Life Sciences Partners (LSP). (11/12/18). "Press Release: LSP Raises Record €750 Million in 10 Months for Life Sciences Innovations [NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY JURISDICTION WHERE U 2018-11-12
Medigene AG. (11/12/18). "Press Release: Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor". Martinsried. 2018-11-12
Medigene AG. (11/12/18). "Press Release: Medigene Reports Financial & Business Results for the First Nine Months of 2018". Planegg. 2018-11-12
Merck KGaA. (11/12/18). "Press Release: Merck Paves the Way for Its Innovation Hub in Southern China". Darmstadt & Guangzhou. 2018-11-12
Mologen AG. (11/12/18). "Press Release: Lefitolimod – First Clinical Data in Combination with a Checkpoint Inhibitor and further Preclinical Results Presented at SITC 2018". Berlin. 2018-11-12
Scienion AG. (11/9/18). "Press Release: R2R Biofluidics EU Project Recently Received the Austrian Fast Forward Award 2018". Berlin. 2018-11-09
CRISPR Therapeutics AG. (11/9/18). "Press Release: CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology". Zug, Cambridge, MA & Gaithersburg, MD. 2018-11-09
Arsanis, Inc.. (11/9/18). "Press Release: Arsanis Reports Financial Results for Third Quarter 2018". Waltham, MA & Vienna. 2018-11-09
Convert Pharmaceuticals S.A.. (11/8/18). "Press Release: Convert Pharmaceuticals Appoints Mariola Söhngen as New CEO". 2018-11-08
Mologen AG. (11/8/18). "Press Release: Implementation of Financing Measures and Publication of Study Results". Berlin. 2018-11-08
Themis Bioscience N.V.. (11/8/18). "Press Release: Themis Bioscience Postpones Its Listing on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. 2018-11-08
Curetis N.V.. (11/7/18). "Press Release: Curetis Raises €8.9 Million through Private Placements [Not for United States, Australia, Canada, Japan or South Africa or any other Jurisdiction where unlawful]". Amsterdam, Holzgerlingen & San Diego, CA. 2018-11-07
CRISPR Therapeutics AG. (11/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results". Zug & Cambridge, MA. 2018-11-07
Spark Therapeutics, Inc.. (11/6/18). "Press Release: Spark Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Progress". Philadeliphia, PA. 2018-11-06
ProBioGen AG. (11/6/18). "Press Release: ProBioGen Announces Successful Bispecific GlymaxX Development Project for Zymeworks". Berlin. 2018-11-06
Genedata AG. (11/6/18). "Press Release: Sartorius Stedim Cellca Licenses Genedata Bioprocess to Streamline Development Operations". Basel. 2018-11-06
MorphoSys AG. (11/5/18). "Press Release: MorphoSys AG Announces Third Quarter 2018 Results". Planegg. 2018-11-05
Boehringer Ingelheim. (11/5/18). "Press Release: Initial Results from EMPRISE Real-world Evidence Study". Ingelheim & Indianapolis, IN. 2018-11-05
Themis Bioscience GmbH. (11/5/18). "Press Release: Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in The Lancet". Vienna. 2018-11-05
Marinomed Biotech AG. (11/5/18). "Press Release: Marinomed Announces Its Intention to Launch an Initial Public Offering and Listing on the Vienna Stock Exchange [Not for US, AU, CA, JP, et al.]". Vienna. 2018-11-05
Immunic AG. (11/5/18). "Press Release: Immunic Enters into a Global Option and License Agreement with Daiichi Sankyo". Planegg-Martinsried. 2018-11-05
BioNTech AG. (11/5/18). "Press Release: BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates against Various Infectious Diseases". Mainz. 2018-11-05
Omeicos Therapeutics GmbH. (11/2/18). "Press Release: Omeicos Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation". Berlin & Boston, MA. 2018-11-02
Curetis N.V.. (11/2/18). "Press Release: Curetis Launches Privately Placed Capital Increase to Raise up to €18.4 Million [NOT FOR THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL]". Amsterdam, Hol 2018-11-02
Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (11/2/18). "Press Release: Dr. Axel Mescheder Appointed CEO of Cristal Therapeutics as Focus Intensifies on Proprietary Oncology Nanomedicine Pipeline". Maastricht. 2018-11-02
Argen-X N.V. (Argenx). (11/1/18). "Press Release: Argenx Announces New Cusatuzumab (ARGX-110) AML Data in Abstracts Published in Connection with 60th American Society of Hematology Annual Meeting and Exposition". Breda & Ghent. 2018-11-01
PerkinElmer, Inc.. (10/31/18). "Press Release: PerkinElmer Announces Financial Results for the Third Quarter of 2018". Waltham, MA. 2018-10-31
[iito] Business Intelligence. (10/31/18). "Press Release: [iito] Discontinues Life-Sciences-Spain.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2018-10-31
Boehringer Ingelheim. (10/31/18). "Press Release: Boehringer Ingelheim Achieves Next Expansion Milestone in Biologics Production in the US". Fremont, CA. 2018-10-31
BioM Biotech Cluster Development GmbH. (10/30/18). "Pressemitteilung: BioM erhält Auftrag zur Projektkoordination von »DigiMed Bayern«. Bayerisches Gesundheitsministerium fördert das medizinische Digitalisierungsvorhaben mit 20 Millionen Euro über 5 Jahr 2018-10-30
Grünenthal GmbH. (10/30/18). "Press Release: Grünenthal Agrees US$ 922 m Deal with AstraZeneca for Nexium and Vimovo". Aachen. 2018-10-30
Thermo Fisher Scientific Inc.. (10/29/18). "Press Release: Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins". Sunnyvale, CA. 2018-10-29
Noscendo GmbH. (10/29/18). "Press Release: Noscendo Closes Financing Round for CE Certification and Market Entry Preparation of Platform Diagnostics for Bloodstream Associated Infections". Duisburg. 2018-10-29
Themis Bioscience N.V.. (10/29/18). "Press Release: Themis Bioscience Launches its Initial Public Offering on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. 2018-10-29
Boehringer Ingelheim. (10/26/18). "Press Release: Boehringer Ingelheim Inaugurates New Centre for Agile Working Methods – More and Better Health Solutions for Humans and Animals". Ingelheim. 2018-10-26
Galecto Biotech AB. (10/26/18). "Press Release: Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development". Copenhagen. 2018-10-26
BASF SE. (10/24/18). "Press Release: BASF Licenses CRISPR-Cpf1 Genome Editing Technology from the Broad Institute of MIT and Harvard". Research Triangle Park, NC. 2018-10-24
Intrexon Corporation. (10/24/18). "Press Release: Intrexon Announces the Formation of Bioinformatics Hub in Munich. Establishing itself as Intrexon Bioinformatics Germany GmbH (IBG)". Germantown, MD. 2018-10-24
Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. 2018-10-24
Novartis AG. (10/23/18). "Press Release: Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgery". Fort Worth, TX. 2018-10-23
Idorsia Ltd.. (10/23/18). "Press Release: Idorsia Announces that Simon Jose Is to Join the Company as Chief Commercial Officer". Alschwil. 2018-10-23
Validogen GmbH. (10/22/18). "Press Release: Change of Company Name – VTU Technology Is Now Validogen". Raaba-Grambach. 2018-10-22
Marinomed Biotech AG. (10/19/18). "Press Release: Initiation of First Marinosolv Clinical Trial (Ph III)". 2018-10-19
Boehringer Ingelheim. (10/19/18). "Press Release: Real-world Study Shows Using Giotrif/Gilotrif (afatinib) Followed by Osimertinib Provides a Median of 27.6 Months of Chemotherapy-free Time in Patients with EGFR Mutation-positive NSCLC". Ingelheim. 2018-10-19
Apceth Biopharma GmbH. (10/19/18). "Press Release: Apceth Biopharma Presents Positive Data Demonstrating Efficacy of Apceth-201 in Preclinical Models of Acute GvHD". Munich. 2018-10-19
Novartis AG. (10/18/18). "Press Release: Novartis Announces Planned Acquisition of Endocyte to Expand Expertise in Radiopharmaceuticals and Build on Commitment to Transformational Therapeutic Platforms". Basel. 2018-10-18
Novartis AG. (10/18/18). "Press Release: Novartis Delivered Strong Growth and Innovation During the Third Quarter, Including Progressing Advanced Therapy Platforms to Drive Future growth". Basel. 2018-10-18
Oncgnostics GmbH. (10/17/18). "Press Release: Cervical Cancer Screening. Oncgnostics Closes further Investment Round". Jena. 2018-10-17
Revolution Medicines, Inc.. (10/16/18). "Press Release: Revolution Medicines Acquires Warp Drive Bio to Expand Drug Discovery Portfolio Focused on Frontier Oncology Targets". Redwood City, CA & Cambridge, MA. 2018-10-16
Genedata AG. (10/16/18). "Press Release: Deep Learning-based Genedata Imagence for Automated High-Content Image Analysis Debuts at SLAS Conference". Basel. 2018-10-16
ERS Genomics Ltd.. (10/16/18). "Press Release: ERS Genomics and Syngulon Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Industrial Applications". Dublin & Seraing. 2018-10-16
Bruker Corporation. (10/16/18). "Press Release: Bruker Launches the S2 Polar High-Performance, Multi-Element Benchtop EDXRF Analyzer for the Petrochemical Industry". Galveston, TX. 2018-10-16
Bruker Corporation. (10/16/18). "Press Release: Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH". Billerica, MA. 2018-10-16
Quantum Analytics. (10/16/18). "Press Release: New Distribution Agreement with Bruker AXS". Foster City, CA. 2018-10-16
F-Star Biotechnology Ltd.. (10/15/18). "Press Release: F-star Appoints Dr Eliot Forster as Chief Executive Officer". Cambridge. 2018-10-15
1 2 3 ... 97 98 99  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px

» top